The effect of passage number on fibroblast cellular senescence in patientswith chronic venous insufficiency with and without ulcer

Citation
Jd. Raffetto et al., The effect of passage number on fibroblast cellular senescence in patientswith chronic venous insufficiency with and without ulcer, AM J SURG, 178(2), 1999, pp. 107-112
Citations number
15
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF SURGERY
ISSN journal
00029610 → ACNP
Volume
178
Issue
2
Year of publication
1999
Pages
107 - 112
Database
ISI
SICI code
0002-9610(199908)178:2<107:TEOPNO>2.0.ZU;2-9
Abstract
BACKGROUND: Fibroblasts (fb) cultured from venous ulcer patients and patien ts with venous reflux disease without ulcer demonstrate characteristics of cellular senescence, such as increased fibronectin level and senescence-ass ociated beta-galactosidase (SA beta-gal) positive cells. Cellular senescenc e is an in vitro event characterized by the progressive loss of proliferati ve capacity with increased passage number, and has been associated with imp aired healing in vivo. This report examines progressive stages of cellular senescence in fb from the distal area (du-fb) and proximal fb (pu-fb) of pa tients with venous ulcer, as well as in distal fb (dr-fb) and proximal fb ( pr-fb) from patients with venous reflux without ulcer, by comparing the pop ulation doubling time (T) and percent SA beta-gal expression. RESULTS: The mean value of T over 6 passages for fb in the ulcer group was 132.5 +/- 29.0 hours for pu-fb and 492.9 +/- 146.2 hours for du-fb (P = 0.0 009). For fb in the reflux group the mean value of T over 5 passages was 79 .3 +/- 12.8 hours for pr-fb and 94.2 +/- 16.8 hours for dr-fb (P = 0.8). Co mparing ulcer and reflux fb, no difference in T was observed between pu-fb and pr-fb (P = 0.6), but a difference was noted between du-fb and dr-fb (P = 0.0004). The mean percent SA beta-gal activity for fb in the ulcer group was 11.2% +/- 3.1% for pu-fb and 63.8% +/- 8.9% for du-fb (P = 0.0001). Ind ividual passages demonstrated significant difference (P <0.05) in SA beta-g al activity between pu-fb and du-fb at early and late passages. No differen ce was noted in SA beta-gal activity for fb in the reflux group or between pu-fb and pr-fb, but comparison between du-fb and dr-fb was significant (63 .8% +/- 8.9% versus 7.8% +/- 2.9%; P = 0.0001). CONCLUSIONS: The in vitro passage of du-fb and pu-fb in chronic venous ulce r patients has an effect on T and cellular senescence as measured by SA bet a-gal activity. Our data further suggest that du-fb are at a more progressi ve stage of cellular senescence when compared with pu-fb, and more importan tly with fb cultured from patients with venous reflux without ulcer. These findings are consistent with impaired wound healing of venous stasis ulcer. The accumulation of senescent fb and a more advanced stage of cellular sen escence of du-fb may explain why repeated episodes of venous ulceration are resistant to conservative treatment and require more aggressive measures o f therapy. Am J Surg. 1999;178:107-112. (C) 1999 by Excerpta Medica, Inc.